New book by Larry Connors Click here Improve your trading - See how
Worn as eyewear by the healthcare provider retrieving the vein, the VASOVISION system offers crisp, clear views of the harvesting tunnel (the area surrounding the vein to be harvested) and can eliminate the strain associated with poorly placed monitors or field of view challenges commonly found in today's operating rooms. The system is lightweight, comfortable and easy to use with fingertip adjustments for brightness and contrast. This new product is part of the leading VASOVIEW Endoscopic Vessel Harvesting (EVH) portfolio of products from MAQUET Cardiovascular, and will be sold separately as well as in combination with other VASOVIEW products.
"VASOVISION is at the forefront of ergonomic visualization technology for endoscopic vessel harvesting. It is exciting to know that MAQUET remains committed to innovation in cardiac surgery products," said Thomas Langdon, M.D., of Omaha Thoracic & Cardiovascular Surgery in Nebraska. Dr. Langdon is also director of cardiovascular surgery at the Alegent Health Heart & Vascular Institute in Omaha.
In EVH, a small incision is made in the leg or arm, through which a device is placed and the vessel harvested for a coronary artery bypass graft (CABG) procedure. This method significantly reduces wound complications, shortens recovery time and improves the patient's cosmetic outcome compared with the traditional open technique that involves an incision down the entire length of the leg or arm.
MAQUET, a global leader in the field, continues to advance EVH technologies with more than 1 million procedures having been performed using MAQUET products worldwide.
"We are strongly committed to further advancing EVH technology and conduit quality in bypass surgery. VASOVISION is another example of our commitment to enhancing the procedure," said Raoul Quintero, President and CEO, MAQUET Cardiovascular U.S. Sales LLC. "We believe we have developed an important visualization system that can help improve the operating room environment for clinicians wishing to perform EVH."
About MAQUET Cardiovascular
The MAQUET Group is the global market leader for Medical Systems, focusing on the Operating Room (OR) and Intensive Care Unit (ICU). The integrated products of MAQUET are specially designed to deliver optimal clinical treatment and therapy concepts within acute care hospitals. MAQUET provides innovative medical solutions from three Divisions:
-- Cardiovascular with products for cardiac assist (intra-aortic balloon
counterpulsation therapy), coronary artery bypass surgery, heart valve
repair, aneurysm and vascular repair, peripheral interventions and
extracorporeal circulation
-- Critical Care for intensive care ventilators and anesthesia machines
-- Surgical Workplaces for OR tables, lights and ceiling service units,
prefabricated OR and ICU suites as well as telemedicine for the OR
integration
MAQUET is a subsidiary of the publicly-listed Swedish group of companies GETINGE AB, a company with over $2.8 billion in revenues (2008 fiscal year) and 12,800 employees worldwide. In 2008 MAQUET itself generated pro-forma revenues (including the acquisition of Datascope Corp.) of over $1.4 billion. The company now has 5,000 employees in 34 international sales and service organizations, as well as a network of more than 200 sales representatives.
www.maquet.com
www.getinge.com
MAQUET - The Gold Standard.
SOURCE MAQUET Cardiovascular
http://www.maquet.com
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.